...
首页> 外文期刊>Gastroenterologie clinique et biologique >Optimal treatment with systemic chemotherapy, complete surgical excision and hyperthermic intraperitoneal chemotherapy for a desmoplastic small round cell tumor in an adult male patient.
【24h】

Optimal treatment with systemic chemotherapy, complete surgical excision and hyperthermic intraperitoneal chemotherapy for a desmoplastic small round cell tumor in an adult male patient.

机译:对于成年男性患者的增生性小圆形细胞瘤,采用全身化疗,完全手术切除和腹膜内高温化疗的最佳治疗方法。

获取原文
获取原文并翻译 | 示例
           

摘要

Desmoplastic small round cell tumor (DSRCT) is a very rare but aggressive malignancy. It is usually observed in males during adolescent and early adulthood. The tumor primarily affects the intra-abdominal serosal and is characterized by distinctive histological and immunophenotypic features and by the specific reciprocal translocation EWS-WT1. Prognosis is mainly poor with a mean survival approximately of 2.5 years. However, long-term survivals have been reported using aggressive multimodal therapy based on complete surgical excision, systemic chemotherapy and radiotherapy. The addition of hyperthermic intraperitoneal chemotherapy in the multimodal approach has been reported in very few cases but no effect on survival has been clearly demonstrated. We report a case of a 51-year old adult patient presenting with a DSRCT treated with aggressive therapy based on systemic chemotherapy, complete cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy, resulting in a long term survival of 4 years.
机译:增生性小圆形细胞瘤(DSRCT)是一种非常罕见但具有侵袭性的恶性肿瘤。通常在青春期和成年早期在男性中观察到。该肿瘤主要影响腹膜内浆膜,其特征在于独特的组织学和免疫表型特征以及特定的易位EWS-WT1。预后主要较差,平均生存期约为2.5年。然而,据报道,采用基于完全手术切除,全身化疗和放疗的积极多式联运疗法可长期生存。在极少数情况下,已经报道了在多式联运方法中增加腹膜内高温化疗的方法,但尚未明确显示其对生存的影响。我们报道了一名51岁的成年患者,其DSCCT接受了基于全身化学疗法的积极治疗,与高热腹膜内化学疗法相关的完整细胞还原手术,可长期存活4年。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号